ARCHIVES

Becker, Brown Testify On Biomedical Funding, Manpower Needs

This article is from The Cancer Letter archive.

Vol. 16 No. 12 | March 23, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

Varmus Pledges to Keep Grants at 2010 Level As Federal Shutdown Looms

April 8, 2011

Group Chairmen Propose Adding Four Trials For High Priority Status

July 6, 1990

In The States: Illinois, Virginia approve Legislation Mandating Coverage of Care In Cancer Clinical Trials

June 4, 1999

Cancergrams Cost $840 Year For All

December 2, 1977

In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire

June 11, 1993